Cellular Senescence: Defining a Path Forward.
By Vassilis G. Gorgoulis, P. Adams, A. Alimonti, D. Bennett, O. Bischof, C. Bishop, J. Campisi, M. Collado, K. Evangelou, G. Ferbeyre and 16 more. Cell, 2019
2,621 citations recorded by the source corpus.
Cellular senescence is a cell state implicated in various physiological processes and a wide spectrum of age-related diseases. Recently, interest in therapeutically targeting senescence to improve healthy aging and age-related disease, otherwise known as senotherapy, has been growing rapidly. Thus, the accurate detection of senescent cells, especially in vivo, is essential. Here, we present a consensus from the International Cell Senescence Association (ICSA), defining and discussing key cellular and molecular features of senescence and offering recommendations on how to use them as biomarkers. We also present a resource tool to facilitate the identification of genes linked with senescence, SeneQuest (available at http://Senequest.net). Lastly, we propose an algorithm to accurately assess and quantify senescence, both in cultured cells and in vivo.
Subfields: Aging, Physiology
View Paper: https://www.semanticscholar.org/paper/c76999c10600b142b6bbce4851ff1f34334a4a14
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Aging
In Physiology
Citations in the corpus
- Senescence and the SASP: many therapeutic avenues (2020, background): “Senescent cells arrest stably, produce a complex secretome (known as the senescence-associated secretory phenotype, SASP), and undergo characteristic changes including transcriptional, epigenetic, morphological, and metabolic alterations (Gorgoulis et al. 2019).”
- Mitochondrial dysfunction in cell senescence and aging (2022, background): “Telomere dysfunction might be caused by telomere shortening during DNA replication (3, 4), replication-independent telomere damage (5), or a variety of other stresses (6).”
- Hallmarks of Cancer: New Dimensions. (2022, background): “Senescence can be induced in cells by a variety of conditions, including microenvironmental stresses such as nutrient deprivation and DNA damage, as well as damage to organelles and cellular infrastructure, and imbalances in cellular signaling networks (115, 117), all of which have been associated w”
- Inflammation and aging: signaling pathways and intervention therapies (2023, background): “net).(371) On the other hand, other technologies, such as machine learning which integrates multi-modal and multidimensional big data, are also important to address the complexity of aging problems (Table 4).”
- The senescence-associated secretory phenotype and its physiological and pathological implications (2024, neutral): “…senescence induced by loss of the phosphatase tumour suppressor PTEN , further deletion of TIMP1 , which encodes metalloproteinase inhibitor 1, reprogrammes the SASP to have a pro-tumorigenic function 106 , suggesting the existence of molecular switches that regulate different SASP modules…”
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments (2022, background): “Aging cells present generally elevated chromatin accessibility, but the genome-wide profile differs depending on the stimulus.(35) During human umbilical vein endothelial cell (HUVEC) senescence, chromatin accessibility, mainly referring to intergenic chromatin along with increased accessibility reg”